Portfolio

PanGenetics

CEO Mark de Boer

Developing therapeutic antibodies in the field of chronic inflammation.

PanGenetics is a clinical stage company developing therapeutic antibodies in the field of chronic inflammation. Its lead program is a fully humanized anti-CD40 antibody.

Human Health

PanGenetics logo

NL

Yalelaan 46
3584 CM Utrecht
The Netherlands

Industry

Biotech

Status

Realised

Location

The Netherlands